Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11078980rdf:typepubmed:Citationlld:pubmed
pubmed-article:11078980lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11078980lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11078980lifeskim:mentionsumls-concept:C0001206lld:lifeskim
pubmed-article:11078980lifeskim:mentionsumls-concept:C0209211lld:lifeskim
pubmed-article:11078980lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:11078980pubmed:issue5lld:pubmed
pubmed-article:11078980pubmed:dateCreated2001-1-3lld:pubmed
pubmed-article:11078980pubmed:abstractTextSlow-release (SR) lanreotide is a long-acting somatostatin analog that has been developed in order to overcome the inconvenience of multiple daily subcutaneous injections of octreotide, required for metabolic control in acromegaly. Lanreotide SR has been found to be well tolerated and effective in reducing GH and IGF-I levels but clinical data are still limited compared with those with subcutaneous octreotide treatment.lld:pubmed
pubmed-article:11078980pubmed:languageenglld:pubmed
pubmed-article:11078980pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:citationSubsetIMlld:pubmed
pubmed-article:11078980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11078980pubmed:statusMEDLINElld:pubmed
pubmed-article:11078980pubmed:monthNovlld:pubmed
pubmed-article:11078980pubmed:issn0804-4643lld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:LegrosJ JJJlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:MockelJJlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:BexMMlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:PaganiGGlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:MontiniMMlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:AbtSSlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:GianolaDDlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:MaiterDDlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:PaganiM DMDlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:VerhelstJ AJAlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:AlbaniGGlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:PoppeKKlld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:PedroncelliA...lld:pubmed
pubmed-article:11078980pubmed:authorpubmed-author:VandewegheM...lld:pubmed
pubmed-article:11078980pubmed:issnTypePrintlld:pubmed
pubmed-article:11078980pubmed:volume143lld:pubmed
pubmed-article:11078980pubmed:ownerNLMlld:pubmed
pubmed-article:11078980pubmed:authorsCompleteYlld:pubmed
pubmed-article:11078980pubmed:pagination577-84lld:pubmed
pubmed-article:11078980pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:meshHeadingpubmed-meshheading:11078980...lld:pubmed
pubmed-article:11078980pubmed:year2000lld:pubmed
pubmed-article:11078980pubmed:articleTitleSlow-release lanreotide in the treatment of acromegaly: a study in 66 patients.lld:pubmed
pubmed-article:11078980pubmed:affiliationDepartment of Endocrinology, Middelheim Ziekenhuis Antwerpen, Belgium. johan.verhelst@ocmw.antwepen.belld:pubmed
pubmed-article:11078980pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11078980pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11078980pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11078980lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11078980lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11078980lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11078980lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11078980lld:pubmed